[HTML][HTML] COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific Reports, 2022 - nature.com
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
M Guarino, V Cossiga, I Loperto, I Esposito… - SCIENTIFIC …, 2022 - iris.unina.it
: Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study.
M Guarino, V Cossiga, I Loperto, I Esposito, R Ortolani… - 2022 - cabidigitallibrary.org
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study.
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific …, 2022 - search.ebscohost.com
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
[PDF][PDF] COVID‑19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double‑centre study
A Fiorentino, G Pontillo, L De Coppi, V Cozza… - Scientific …, 2022 - scienceopen.com
Methods Study design and target population. This is a prospective double-centre study
launched after the outbreak of COVID-19 in Italy on 9th of March 2020. The study was …
launched after the outbreak of COVID-19 in Italy on 9th of March 2020. The study was …
[HTML][HTML] COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific …, 2022 - ncbi.nlm.nih.gov
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific …, 2022 - ui.adsabs.harvard.edu
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study.
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific …, 2022 - europepmc.org
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study.
M Guarino, V Cossiga, I Loperto, I Esposito… - Scientific …, 2022 - europepmc.org
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …
immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID …